JPWO2023191082A5 - - Google Patents
Info
- Publication number
- JPWO2023191082A5 JPWO2023191082A5 JP2024512930A JP2024512930A JPWO2023191082A5 JP WO2023191082 A5 JPWO2023191082 A5 JP WO2023191082A5 JP 2024512930 A JP2024512930 A JP 2024512930A JP 2024512930 A JP2024512930 A JP 2024512930A JP WO2023191082 A5 JPWO2023191082 A5 JP WO2023191082A5
- Authority
- JP
- Japan
- Prior art keywords
- component
- low
- cationic
- ionic liquid
- absorption enhancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022060469 | 2022-03-31 | ||
| PCT/JP2023/013657 WO2023191082A1 (ja) | 2022-03-31 | 2023-03-31 | 低溶解性および／または低膜透過性薬物の吸収性が改善された製剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023191082A1 JPWO2023191082A1 (https=) | 2023-10-05 |
| JPWO2023191082A5 true JPWO2023191082A5 (https=) | 2026-03-11 |
Family
ID=88202476
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024512930A Pending JPWO2023191082A1 (https=) | 2022-03-31 | 2023-03-31 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20250205339A1 (https=) |
| EP (1) | EP4501358A4 (https=) |
| JP (1) | JPWO2023191082A1 (https=) |
| CN (1) | CN119300864A (https=) |
| WO (1) | WO2023191082A1 (https=) |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040028613A1 (en) * | 2001-06-25 | 2004-02-12 | Nastech Pharmaceutical Company Inc | Dopamine agonist formulations for enhanced central nervous system delivery |
| AU2008327436B2 (en) * | 2007-11-22 | 2013-09-05 | Medrx Co., Ltd. | External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| KR102272671B1 (ko) | 2013-05-02 | 2021-07-06 | 노보 노르디스크 에이/에스 | Glp-1 화합물의 경구 투여 |
| JP6482570B2 (ja) * | 2014-10-30 | 2019-03-13 | 旭化成株式会社 | 経皮吸収促進剤及び経皮吸収促進助剤 |
| BR112018008918A8 (pt) * | 2015-11-02 | 2019-02-26 | Univ Yale | compostos de quimera proteólise dirigida e métodos para preparação e uso dos mesmos |
| US11446253B2 (en) * | 2017-11-17 | 2022-09-20 | President And Fellows Of Harvard College | Ionic liquids for internal delivery |
| AU2021241095A1 (en) * | 2020-03-26 | 2022-10-27 | Kyushu University, National University Corporation | Ionic liquid, solvent, preparation, and transdermally absorbable agent |
-
2023
- 2023-03-31 US US18/852,301 patent/US20250205339A1/en active Pending
- 2023-03-31 CN CN202380043670.9A patent/CN119300864A/zh active Pending
- 2023-03-31 JP JP2024512930A patent/JPWO2023191082A1/ja active Pending
- 2023-03-31 WO PCT/JP2023/013657 patent/WO2023191082A1/ja not_active Ceased
- 2023-03-31 EP EP23781090.8A patent/EP4501358A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nibha et al. | An overview on: Sublingual route for systemic drug delivery | |
| Liew et al. | Characterization of oral disintegrating film containing donepezil for Alzheimer disease | |
| AU2010330750B2 (en) | Methods and compositions for stable liquid drug formulations | |
| US20060051406A1 (en) | Formulation of insoluble small molecule therapeutics in lipid-based carriers | |
| AU2019274772B2 (en) | Pharmaceutical formulation | |
| EP4021405B1 (en) | Pharmaceutical formulation | |
| EP2453743B1 (en) | N-acetyl cysteine compositions and their use in improving the therapeutic efficacy of acetaminophen | |
| US20080260823A1 (en) | Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea | |
| AU2024203035B2 (en) | Fast disintegrating tablet | |
| WO2019202521A1 (en) | Oral disintegrating film compositions of paracetamol | |
| US11179331B1 (en) | Oral soluble film containing sildenafil citrate | |
| JPWO2023191082A5 (https=) | ||
| US20220047504A1 (en) | Oral dissolvable film with pores extending therethrough | |
| JP4958558B2 (ja) | 非ステロイド系抗炎症薬剤を備え、良好な風味を有する経口投与製剤 | |
| WO2022040435A1 (en) | Nanodrugs for targeted drug delivery and use thereof | |
| EP2500016A1 (en) | Doxylamine resinate complex | |
| KR20080034166A (ko) | 감각기관 수용성 이부프로펜 경구 투약 제형 및 동일물의제조 및 사용 방법 | |
| Ali et al. | Development and characterization of ketorolac tromethamine osmotic pump tablets | |
| JP2001072578A (ja) | 口腔内速崩壊錠 | |
| US20180318209A1 (en) | Film compositions of samidorphan and buprenorphine | |
| ES2402865T3 (es) | Formulación farmacéutica que contiene fluvastatina | |
| Senthil et al. | Levocetirizine dihydrochloride and ambroxol hydrochloride oral soluble films: Design, optimization, and patient compliance study on healthy volunteers | |
| US20070092561A1 (en) | Water-Soluble Aspirin Composition | |
| Daugherty et al. | Rapid Sublingual Absorption of Cyclobenzaprine (CBP) with Basifying Agents: Prospect for Bedtime Treatment of Fibromyalgia Syndrome (FM) | |
| JP7231198B2 (ja) | 医薬用錠剤 |